Adverse change in low-density lipoprotein subfractions profile with oestrogen-only hormone replacement therapy.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  QJM : monthly journal of the Association of Physicians

• Publication date

  1996-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/QJMED/89.10.771PMID 8944233
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic men.

  1996cited by this paper
• Reduced Mortality Associated With Long‐Term Postmenopausal Estrogen Therapy

  1996cited by this paper
• Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolemia among postmenopausal women

  1995cited by this paper
• Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial

  1995cited by this paper
• Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women.

  1994cited by this paper
• Heterogeneity of plasma low‐density lipoproteins and atherosclerosis risk

  1994cited by this paper
• The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women.

  1994cited by this paper
• Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and alpha-tocopherol content.

  1994cited by this paper
• Characterization of low‐density lipoprotein subclasses: methodologie approaches and clinical relevance

  1994cited by this paper
• High-density lipoprotein subfractions measured in stored serum.

  1994cited by this paper
• Particle size: the key to the atherogenic lipoprotein?

  1994influential reference
• Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased?

  1994cited by this paper
• Atherosclerosis and arterial influx of lipoproteins.

  1994cited by this paper
• Plasma cholesteryl ester transfer protein.

  1993cited by this paper
• Response of plasma low density lipoprotein subfractions to oestrogen replacement therapy following surgical menopause

  1993cited by this paper
• Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia.

  1993cited by this paper
• Differences in the low density lipoprotein subfraction profile between oral contraceptive users and controls.

  1993cited by this paper
• Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women.

  1993cited by this paper
• Low density lipoprotein particle size and coronary artery disease.

  1992cited by this paper
• Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women

  1992cited by this paper
• Beneficial effects on serum lipoproteins by 17 beta-oestradiol-dydrogesterone therapy in postmenopausal women; a prospective study.

  1992cited by this paper
• Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins.

  1992cited by this paper
• Correlations of plasma lipoproteins with LDL subfractions by particle size in men and women.

  1992cited by this paper
• Comparison of transdermal and oral estrogen‐progestin replacement therapy: Effects on serum lipids and lipoproteins

  1992cited by this paper
• The risk of acute myocardial infarction after oestrogen and oestrogen‐progestogen replacement

  1992cited by this paper
• Cardiovascular benefits of estrogen replacement therapy.

  1989cited by this paper
• Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women.

  1988cited by this paper
• Dose and duration effects of oestradiol valerate on serum apolipoproteins A1 and B.

  1987cited by this paper
• Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.

  1987cited by this paper
• Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population.

  1986cited by this paper
• Coronary heart disease in relation to age, sex, and the menopause.

  1978cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper

• Impact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women?

  2017cites this paper
• Lipid profile in normal pregnancy

  2012cites this paper
• "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses.

  2011cites this paper
• Low- and standard-estrogen dosage in oral therapy: dose-dependent effects on insulin and lipid metabolism in healthy postmenopausal women

  2008cites this paper
• Hormone Therapy, Lipoprotein Subclasses, and Coronary Calcification

  2005cites this paper
• Hormone therapy, lipoprotein subclasses, and coronary calcification: the Healthy Women Study.

  2005cites this paper
• Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetes.

  2004cites this paper
• Evidence of Increased Oxidative Stress, Unexplained by Lipid Changes, Is Present in Nulliparous Black Women from Early Gestation

  2004cites this paper
• Lipoprotein compositional changes with combination hormone therapy (conjugated estrogen and medroxyprogesterone) in African American women.

  2004cites this paper
• Supraphysiological concentrations of estradiol in menopausal women given repeated implant therapy do not adversely affect lipid profiles.

  2002influential citation
• Oxidative stress and normal pregnancy

  2002cites this paper
• The effect of oral hormone replacement therapy on lipoprotein profile, resistance of LDL to oxidation and LDL particle size.

  2001cites this paper
• Underuse of Antithrombotic Therapy in Stroke Patients With Chronic Atrial Fibrillation

  2000cites this paper
• Association between elevated plasma fibrinogen and the small, dense low-density lipoprotein phenotype among postmenopausal women.

  2000cites this paper
• Underuse of antithrombotic therapy in stroke patients with chronic atrial fibrillation.

  2000cites this paper
• Hormone replacement therapy and intima-media thickness of the common carotid artery: the Rotterdam study.

  2000cites this paper
• Underuse of Antithrombotic Therapy in Stroke Patients With Chronic Atrial in Patients With and to the Editor

  2000cites this paper
• Underuse of Antithrombotic Therapy in Stroke Patients With Chronic Atrial in Patients With and Letters to the Editor

  2000cites this paper
• Low Incidence of Stroke in the Chiquitanos Tribe in the Bolivian Lowlands

  2000cites this paper
• Is normal pregnancy atherogenic?

  1999cites this paper
• The effects of estrogens and phytoestrogens on the metabolism and oxidation of plasma lipoproteins / Alice Jane Owen.

  1999cites this paper
• Low-density lipoprotein subfraction profiles in chronic renal failure.

  1998cites this paper
• Lipid and Lipoprotein Responses to Oral Combined Hormone Replacement Therapy in Normolipemic Obese Women with Controlled Type 2 Diabetes Mellitus

  1998cites this paper
• Effects of oral combined hormone replacement therapy on plasma lipids and lipoproteins.

  1998cites this paper